-
Dr Pavan Gorukanti, Director, Yashoda Hospital, said they were proud to be the front runner in the space of vaccination and preventive care.
-
The company said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.
-
The US drug maker informed Pfizer that its falling short of Bicillin -- a long-acting injectable form of the antibiotic penicillin
-
Hyderabad: Pfizer India on Monday announced the launch of ‘Open-AMR’, a free online platform to educate nurses on Antimicrobial Resistance (AMR) in English and other regional languages including Telugu. The Open-AMR initiative is a web-based platform that can be accessed by any nurse anywhere in India for free in seven different languages including English, Hindi, […]
-
Washington: Pfizer and its German partner BioNTech have said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old at preventing illness during the Omicron wave. The vaccine was found to elicit a strong immune response following a third dose, and was […]
-
Bengaluru: Predictive studies opine that the 4th wave of the Covid-19 will start in June-July and last till September, stated Karnataka Health Minister K. Sudhakar on Tuesday. “Karnataka is prepared to face it,” he added. He said that there is no need to worry as of now. The new XE variant of Covid-19 is prominent […]
-
Hyderabad: Continuing his efforts to get investments into Telangana, Industries Minister KT Rama Rao met senior officials of world’s largest pharma companies, including Pfizer, J&J and GSK in the United States on Friday. The three companies together represent more than 170 billions US dollars in annual revenue and the combined employee strength of these organizations […]
-
Hyderabad: Three pharma companies from Hyderabad have entered into agreement with UN-backed Medicines Patent Pool (MPP), headquartered in Geneva, to manufacture and supply a generic version of Pfizer’s Covid-19 oral treatment Nirmatrelvir. Aurobindo Pharma said it signed a sub-license agreement with MPP. Earlier, MPP signed voluntary licensing agreement with Pfizer for sub-licensing this Covid-19 treatment […]
-
Hong Kong: Despite low absolute risk, there is an increased relative risk of carditis — a type of heart inflammation — associated with Covid vaccine developed by US drugmaker Pfizer and China’s CoronaVac, researchers have found. The findings, published in Annals of Internal Medicine, show a significant increased risk in adolescents after the second dose. […]
-
London: A third ‘booster’ dose of Covid-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings. Published as a research letter in The Lancet, researchers including from the Francis Crick Institute and UCLH Biomedical Research, found that antibodies generated in people who had received only two doses of either the […]
-
Washington: Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalisations and deaths by about 89 per cent among high-risk adults when taken shortly after […]
-
Johannesburg: Pfizer’s mRNA-based Covid vaccine may be up to 40 times less effective against the new super mutant Omicron variant, a small study led by South African researchers have shown. The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that, based on the large number of mutations in […]
-
The global fears over the emergence of Omicron, the new and more virulent coronavirus variant, once again highlight an often neglected aspect of the pandemic: Vaccine inequality. The widening gulf between the rich and the poor nations in terms of inoculation coverage makes the fight against the virus less effective. Access to life-saving vaccines makes […]
-
Hyderabad: The Biden administration has announced revised international air travel rules for those flying to the United States, with the rules to come into effect from November 8. According to a communiqué from the White House, details of which are available on www.cdc.gov/ and https://travel.state.gov/content/travel.html as well, starting November 8, all foreign national air travellers […]
-
The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.
-
Even 15 weeks after the first dose, eight of 10 people still had detectable germinal centers containing B cells targeting the virus.
-
The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna.
-
The Pfizer/BioNTech COVID-19 vaccine is already approved for use in adults and adolescents aged 16 years and above.
-
The Centre should consider utilising its position as the monopolistic buyer in the market and pass down the benefit to all people
-
Experts say hospitalisation, mortality likely to rise among the age group
